Trials / Recruiting
RecruitingNCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 13,000 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | Participants will have their blood drawn and cognitive score measured by the ISLT. |
Timeline
- Start date
- 2025-07-02
- Primary completion
- 2035-07-31
- Completion
- 2035-07-31
- First posted
- 2025-09-17
- Last updated
- 2026-04-06
Locations
211 sites across 14 countries: United States, Argentina, Australia, Brazil, Canada, China, Denmark, Italy, Japan, Poland, Puerto Rico, South Korea, Spain, Taiwan
Source: ClinicalTrials.gov record NCT07177352. Inclusion in this directory is not an endorsement.